Radiobiology: : A changing science. ca Classical Radiobiology. Phenomenology. Modelling. Understanding of Mechanisms. today
|
|
- Lee Tyler
- 5 years ago
- Views:
Transcription
1 Modern Radiobiology State of the Art and Future Perspectives H. Peter Rodemann Division of Radiobiology and Molecular Environmental Research Dept. of Radiation Oncology Eberhard-Karls-University Tübingen
2 Radiobiology: : A changing science Skin alterations Death of cells ca Classical Radiobiology Linear-Quadratic Model of cell inactivation Role of p53 and inter- as well as intracellular signal transduction today Definition of molecular targets Phenomenology Modelling Understanding of Mechanisms Molecular Radiobiology major input to radiation oncology
3 What are the future perspectives? Identification of molecular targets for radiosensitization / radioprotection in the context of their normal and pathological mechanisms Identification of tissue specific target structures on the basis of biological / molecular imaging Identification of genetic markers of individual radiation sensitivity (Genomics / Proteomics) Development of molecular prediction for RT (Theranostics) Application of stem cells to rescue damaged normal tissue
4 Target identification Cytokine signaling determins NT responses If we understand all the details, the most Growth factor and cell relevant matrix molecular mediated survival targets can be defined to signaling determin develop the TT best responses possible therapeutic strategy in RO! Molecular Targeting Strategies
5 Functional molecular imaging high resolution PET-CT / PET-MRI
6 Genomics DNA microarray Actin DNA CyclinD1 DNA DHFR DNA 8 RB DNA E2F1 DNA tubulin DNA
7 Prognostic profiling Metastasis Nature, Vol 415, 31 January 2002
8 Proteomics 2D-PAGE (ph range 4-7) of non-irradiated lymphocytes from normal, radiation sen- sitive and radiation resistant identical twins! normal 87 proteins sensitive 12 proteins resistant +15 proteins
9 Theranostics Theranostics: link between diagnostics and therapy DNA-Chips Protein chips Predisposition Profiling Diagnostics Medical Imaging Diagnostics in vitro Diagnostics Molecular Imaging Treatment, Selection / Refinement Pharmacogenomics Image guidance Therapeutic Intervention Home Monitoring Diagnostic Devices Molecular Imaging Treatment Monitoring
10 The Holthusen-Principle Principle is still valid Implementation of available data sets will selectively improve tumor response % Tumor Response % Normal Tissue reaction rel. total dose
11 The Holthusen-Principle Principle is still valid Implementation of available data sets will help to selectively protect normal tissue % Tumor Response % Normal Tissue reaction rel. total dose
12 Molecular Targeting Strategies to improve tumor and prevent normal tissue reponses EXAMPLE 1 : EGF-Receptor antagonists as target to improve tumor response EXAMPLE 2 : TGFß1-production production/signaling as target to prevent radiation- induced fibrosis EXAMPLE 3 : Bowman Birk Protease Inhibitor (BBI) and Phospho- Tyrosine as tools to selectively protect normal tissue
13 EGFR
14 EGFR overexpression in human tumors Solid tumors presenting overexpressed or mutated EGFR H&N % Renal 50-90% Breast 14-91% Esophageal 43-89% Prostate 40-80% NSCLC 40-80% Colorectal 25-77% Gastric 33-74% Ovarian 35-70% Glioma 40-63% Pancreatic 30-50% Bladder 31-48% overexpression / mutation is associated with enhanced receptor signaling massive tumor growth enhanced invasive and metastatic potential and is generally correlated with resistance to chemo-/ radiotherapy
15 EGFR overexpression in human tumors Bonner et al. New Engl J Med H&N tumor patients : 213 RT+Cetuximab (C225) / 211 RT alone Locoregional Control (%) RT plus C225 RT Overall Survival (%) RT plus C225 RT Months Months
16 EGFR signaling Cytoplasmic EGFR pathways Nuclear EGFR pathways PLC PI3K Ras STATs Nuclear Targets E2F1 STAT3 Cyclin D1 B-Myb inos Cell Survival, Proliferation Tumorigenesis, Metastasis Chemo- & Radioresistance G1-S-Progression Proliferation Proliferation Metastasis
17 Activated EGF receptor and its cellular consequences ligand - + -IR +2Gy P-EGFR P-EGFR Ras PI3K STAT Raf AKT MEK mtor MAPK Proliferation Cell Cycle Control Survival Proliferation Radioresistance
18 Targeting EGFR signaling small molecule tyrosine kinase inhibitor (SMI) mtor EGFR- TK PI3K AKT monoclonal antibody (mab) STAT Ras Raf MEK MAPK Proliferation Cell Cycle Control Survival Proliferation Radioresistance Radiosensitization
19 C225 leads to radiosensitization in vitro and in vivo Harari et al IJROBP 49: Krause et al Radiother. Oncol. 74: Clonogenic assay in vitro H&N SCC cell lines Tumor Control Study in vivo FaDu tumor xenograft model
20 Effect of C225 on localisation of DNA-PK Huang et al Clin. Cancer Res. 6:
21 Radiation-induced EGFR signaling Güven et al. J Biol Chem 2001 Genes Chromos Cancer 2003 PLC PI3K Ras STATs Dittmann et al. J Biol Chem 2005 Radiother Oncol 2005 Radiother Oncol 2007 Int J Rad Oncol Biol Phys 2008 Radiother Oncol 2008 DNA-PK DNA-Repair via NHEJ DNA-PK DNA-Repair via NHEJ Toulany et al. Radiother Oncol 2005a Radiother Oncol 2005b Clin Cancer Res 2006 Mol Cancer Res 2007 Rodemann et al. Sem Rad Oncol 2007 Int J Rad Biol 2007 Radioresistance Radioresistance
22 C225 prevents radiation-induced induced nuclear translocation of EGFR and activation of DNA-PK Dittmann et al. J. Biol. Chem C225 EGFR EGFR DNA-PK DNA-DSB? REPAIR
23 C225 mediates impaired DNA-DSB repair and enhances radiation sensitivity Dittmann et al. J. Biol. Chem. 2005
24 Specific inhibition of EGFR-tyrosine kinase activity Ligand Ligand BIBX1382BS TKI R R K K TKI highly selective inhibitor of EGFR tyrosine kinase chemical class: pyrimido-[5,4-d]- pyrimidine-2,8-diamine,n8-(3- chloro-4-fluorophenyl) binds directly to intracellular tyrosine-kinase domain inhibits ligand-induced cell growth - erbb1-cells IC 50 = 0.01 µm - erbb2-cells IC 50 = 1.0 µm
25 Differential radiation response of Ras wt or Ras mt tumor cells to BIBX1382BS Toulany et al. Clin. Cancer Res Single dose irradiation K-RAS mt A549 cells K-RAS wt FaDu cells 1 Clonogenic fraction 0.1 A549 Controls BIBX FaDu Controls BIBX X-ray dose, Gy X-ray dose, Gy
26 Differential radiation response of Ras wt or Ras mt tumor cells to BIBX1382BS Toulany et al. Radiother. Oncol Fractionated dose irradiation (4 x 2 Gy) K-Ras mutated cell lines K-Ras wildtype cell lines SF(± SD) IR BIBX,IR Total Dose (Gy) 0.01 (2 Gy fractions) IR BIBX,IR Total Dose (Gy) DMF for Ras mt cell lines A549, MDA-MB231, PC3 No effect in normal Ras cell lines FaDu, HTB35/SiHa, HH4DD
27 Autocrine activation of EGFR-PI3K-AKT signaling in K-RAS mt cells Toulany et al Radiother. Oncol. 76: EGFR- TK Ras Ras Amphiregulin TGFa PI3K Raf AKT MEK Radioressistance Relative SF ( ± SD ) HTB-35 CM, 2 Gy A549 CM, 2 Gy vehicle, 2 Gy MAPK Proliferation CREB
28 Role of AKT in regulating DNA-PK Toulany et al., Clin Cancer Res 2006 Toulany et al., Mol Cancer Ther 2008 in press EGFR/erbB-1 EGFR-spec.TK-.TK-inh. (BIBX) PI3K LY Post 2 Gy (min) P-Akt IP: P-Akt PDK1/2 Akt P-T2609 IR (2 Gy) Akt P-T2609 DNA-PK con sirna Akt sirna Akt- sirna P Akt P DNA-PK API Surviving fraction DNA-PK control BIBX Gy Gy DNA-DSB repair is through markedly non inhibited! homologous RADIOSENSITIZATION endjoining NHEJ
29 EGFR / PI3K inhibitors mediate enhanced residual DNA-damage Toulany et al. Clin. Cancer Res γ-h2ax-foci indicating residual DNA-DSB 24h after IR K-Ras mt A549 K-Ras wt FaDu A Gy A549 + BIBX + 6 Gy Number of γ H2AX foci per cell Gy BIBX / 2 Gy 6 Gy BIBX / 6 Gy LY/ 6 Gy 2 Gy BIBX / 2 Gy 6 Gy BIBX / 6 Gy LY/ Gy
30 Importance of EGFR-signaling for DNA-DSB repair in K-Ras mt tumor cells EGFR- TK PI3K EGFR- TK Ras Raf nuclear translocation AKT Apoptosis MEK MAPK EGFR-TK DNA-PK DNA-PK DNA-DSB repair (NHEJ) Proliferation
31 Importance of EGFR-signaling for DNA-DSB repair in K-Ras mt tumor cells EGFR- TK PI3K EGFR- TK C225 BIBX LY Ras Raf nuclear translocation API-59 AKT Apoptosis MEK MAPK EGFR-TK DNA-PK DNA-PK DNA-DSB repair (NHEJ) repair (NHEJ) Proliferation enhanced radiation sensitivity
32 TGFß
33 Tissue responses resulting in radiation-induced induced fibrosis of the lung (Rübe et al. 2004) Bronchial Epithelium Inflammatory cytokines Alveolar macrophages Alveoli Pneumo- cytes Capillary Endothelial cells Fibrogenic Cytokines TGF-ß PDGF, TGF-ß Inflammatory process FIBROSIS Collagen Fibroblasts Fibrocytes
34 TGFß1-signaling and potential targets for intervention LTGFβ1 LTGFβ1 Mn-SOD ROS / Amifostine Epperly et al / TGFβ1-Gene Vujaskovic expression 2002 TF Smad 2/3 Smad4 Smad 2/3 GTCAGAC Amifostine Vujaskovic ROS et al proteolytic protease activation inhibitors e.g. Furin Haase et al P P P P anti-tgfβ1-ab TGF TGFβ1 Hakenjos active et al 2000 TGFβ1 R2 R1 Smad4 Kinase-Inh. R2 R1 Wiegman et al Smad7 P Smad 2/3 Smad 2/3 Smad4 Smad 2/3 TGFβ1 P P P P P P Smad 2 Smad 3 gene expression, e.g. p21, p27, collagen
35 Radiation-induced induced lung fibrosis (Vujaskovic et al. 2002) Rat lung Total collagen production TGFß1 production before RT 6 month after IR (SD 28 Gy)
36 Amifostine prevents manifestation of radiation-induced induced fibrosis of the lung by inhibiting TGF-ß production 150 mg/kg amifostine 30 min before IR (Vujaskovic et al. 2002) activation of proteolytic enzymes Amifostine ROS LTGFß TGFß1 gene expression TGFß
37 BBI / ptyr
38 Bowman-Birk Birk Proteinase Inhibitor (BBI) and ptyr 30 1 Asn Asp Asp Glu Ser Leu Ser Ser 40 Arg Cys Met His Asp Lys Cys Ile 20 Ser Ser Arg Cys Pro Ser Cys Ala Pro Gln Cys Lys Ala Pro Cys Cys Lys Cys Pro Cys Cys 10 Asp Asn Cys Pro Cys Phe Ser Gln Ala Ala Gln Glu 50 Val Thr 60 Glu Cys Tyr Asp Ser Lys Ile Cys Thr Asp Phe Asp Asp Lys Glu Asn 70 Leu Ser Tyr Pro phospho-tyrosine (ptyr)
39 BBI affects normal and tumorigenic human fibroblasts differentially (Dittmann et al.1995) Normal human skin fibroblasts Transformed, tumorigenic human skin fibroblasts HSF1 HH4dd wildtype p53 mutated p53
40 BBI affects p53 wt and p53 mt tumor cells differentially (Dittmann et al.1998) lung adeno carcinoma cell line A549 presenting wildtype p53 lung adeno carcinoma cell line A549 transfected w/ mutated p53 wildtype p53: functional mutated p53: non-functional
41 Stimulation of DNA-DSB-repair by P-Tyr in p53 wt cells (Dittmann et al ) γ-h2ax-focus assay was used for determination of residual DNA-DSB 24 h post IR fibroblasts, p53 wt 0 2 6
42 Mode of action of BBI and ptyr pre-irradiation treatment with BBI / ptyr EGFR Dittmann et al. Radiother. Oncol 2008 Wanner et al. Radiother. Oncol 2008 Dittmann et al. Radiother. Oncol 2007 Dittmann et al. Int. J. Rad. Biol Dittmann et al. Curr. Med. Chem Dittmann et al. Int. J. Cancer 2001 P p53wt? Activation of DNA- repair machinery Enhanced cell survival post IR
43 BBI effect in vivo: normal tissue vs. tumor response (Dittmann et al. 2005) Leg contracture assay Tumor growth delay assay C3H-mice were treated 3x with different doses of BBI at day 2, day -1, and day 0 before IR; both hind legs were irradiated w/ SD of 55 Gy. Leg contracture was quantified up to 120 days post IR.
44 Current impact of proposed perspectives Identification of molecular targets for radiosesiti- zation / radioprotection in the context of their nor- mal and pathological mechanisms Identification of tissue specific target structures on the basis of biological / molecular imaging Identification of genetic markers of individual radiation sensitivity (Genomics / Proteomics) Development of molecular prediction for RT (Theranostics) Application of stem cells to rescue damaged normal tissue
45 Thanks to the co-workers current staff Klaus Dittmann, PhD Petra Ohneseit, PhD Mahmoud Toulany, PhD Nadine Hoffmann, Techn. Simone Keinath, Techn. Heidi Löffler, Techn. Claus Mayer, Techn. Urszula Florczak, PhD-Stud. Gerd Krötzinger, MD-Stud. Julia Mihatsch, PhD-Stud. Minjma Minjgee, PhD-Stud. Christine Rothmund, PhD-Stud. Gabriele Wanner, PhD-Stud.... former postdocs, PhD- / MD-students, and guest scientists... and to you! Marcel Bläse / Anke Burger / Anke Binder Lydia Hakenjos / Oliver Haase / Carsten Herskind / Sonja Nolte / Andreas von Pfeil / Erwin Wiegman / Weiguo Xu
EGFR: fundamenteel en klinisch
EGFR: fundamenteel en klinisch Guido Lammering MAASTRO Clinic Maastricht, NL What is EGFR?? The EGFR some facts 1186 amino acids 170 kda Expressed by all cells of epithelial origin Increased activation
More informationoncogenes-and- tumour-suppressor-genes)
Special topics in tumor biochemistry oncogenes-and- tumour-suppressor-genes) Speaker: Prof. Jiunn-Jye Chuu E-Mail: jjchuu@mail.stust.edu.tw Genetic Basis of Cancer Cancer-causing mutations Disease of aging
More informationTOPICS. Primary Radiation Therapy. Targeted Therapy in Oncology. Principles of Radiation Therapy. Principles of Radiation Therapy
Peter B. Schiff, M.D., Ph.D. Department of Radiation Oncology Columbia University College of Physicians & Surgeons May 4, 2007 Targeted Therapy in Oncology Surgical Oncology Minimal invasive techniques
More informationBreast Cancer: the interplay of biology, drugs, radiation. Prof. L. Livi Università degli Studi di Firenze. Brescia, October 3rd 4th, 2013
Breast Cancer: the interplay of biology, drugs, radiation Prof. L. Livi Università degli Studi di Firenze Brescia, October 3rd 4th, 2013 BACKGROUND (1) The complex interactions between tumor-specific signaling
More informationUNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA PhD SCHOOL. PhD THESIS
UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA PhD SCHOOL PhD THESIS THE IMPORTANCE OF TUMOR ANGIOGENESIS IN CEREBRAL TUMOR DIAGNOSIS AND THERAPY ABSTRACT PhD COORDINATOR: Prof. univ. dr. DRICU Anica PhD
More informationDiscovery and Optimization of Inhibitors of STAT3 Activation for the Treatment of Squamous Cell Carcinoma of the Head and Neck
Discovery and ptimization of Inhibitors of STAT3 Activation for the Treatment of Squamous Cell Carcinoma of the Head and Neck Feng Zhang Wipf Group Research Topic Seminar 02-09-2013 1 Feng Zhang @ Wipf
More informationCHAPTER VII CONCLUDING REMARKS AND FUTURE DIRECTION. Androgen deprivation therapy is the most used treatment of de novo or recurrent
CHAPTER VII CONCLUDING REMARKS AND FUTURE DIRECTION Stathmin in Prostate Cancer Development and Progression Androgen deprivation therapy is the most used treatment of de novo or recurrent metastatic PCa.
More informationRadiobiology of high dose per fraction
Radiobiology of high dose per fraction Michael Joiner Wayne State University Radiation Oncology Detroit, Michigan joinerm@wayne.edu AAPM 2014 Historically Research focused on clinically relevant doses
More informationWhat causes cancer? Physical factors (radiation, ionization) Chemical factors (carcinogens) Biological factors (virus, bacteria, parasite)
Oncogenes What causes cancer? Chemical factors (carcinogens) Physical factors (radiation, ionization) Biological factors (virus, bacteria, parasite) DNA Mutation or damage Oncogenes Tumor suppressor genes
More informationRadiobiology of fractionated treatments: the classical approach and the 4 Rs. Vischioni Barbara MD, PhD Centro Nazionale Adroterapia Oncologica
Radiobiology of fractionated treatments: the classical approach and the 4 Rs Vischioni Barbara MD, PhD Centro Nazionale Adroterapia Oncologica Radiobiology It is fundamental in radiation oncology Radiobiology
More informationAACR 101st Annual Meeting 2010, Washington D.C. Experimental and Molecular Therapeutics Section 29; Abstract #3855
Investigation of the Growth Inhibitory Activity of the MEK Inhibitor ARRY-162 in Combination with Everolimus in a Variety of KRas and PI3K Pathway Mutant Cancers Brian Tunquist, Tyler Risom, Debbie Anderson,
More informationFGL2 A new biomarker for cancer in a simple blood test
FGL2 A new biomarker for cancer in a simple blood test WHO IS FGL2 Human gene (chromosome 7) is 7 kb long, 2 exons, monomer protein 70 KD, tetramer in solution. Fibrinogen-like protein 2 (Fgl2), a member
More informationDeregulation of signal transduction and cell cycle in Cancer
Deregulation of signal transduction and cell cycle in Cancer Tuangporn Suthiphongchai, Ph.D. Department of Biochemistry Faculty of Science, Mahidol University Email: tuangporn.sut@mahidol.ac.th Room Pr324
More informationNon-classical radiobiology relevant to high-doses per fraction
Non-classical radiobiology relevant to high-doses per fraction Michael Joiner Wayne State University Radiation Oncology Detroit, Michigan joinerm@wayne.edu Why reconsider high dose fractions? Because we
More informationSignaling. Dr. Sujata Persad Katz Group Centre for Pharmacy & Health research
Signaling Dr. Sujata Persad 3-020 Katz Group Centre for Pharmacy & Health research E-mail:sujata.persad@ualberta.ca 1 Growth Factor Receptors and Other Signaling Pathways What we will cover today: How
More informationSupplementary Figure 1: si-craf but not si-braf sensitizes tumor cells to radiation.
Supplementary Figure 1: si-craf but not si-braf sensitizes tumor cells to radiation. (a) Embryonic fibroblasts isolated from wildtype (WT), BRAF -/-, or CRAF -/- mice were irradiated (6 Gy) and DNA damage
More informationOncogenes and Tumor. supressors
Oncogenes and Tumor supressors From history to therapeutics Serge ROCHE Neoplastic transformation TUMOR SURESSOR ONCOGENE ONCOGENES History 1911 1960 1980 2001 Transforming retrovirus RSV v-src is an oncogene
More information1. The metastatic cascade. 3. Pathologic features of metastasis. 4. Therapeutic ramifications. Which malignant cells will metastasize?
1. The metastatic cascade 3. Pathologic features of metastasis 4. Therapeutic ramifications Sir James Paget (1814-1899) British Surgeon/ Pathologist Paget s disease of Paget s disease of the nipple (intraductal
More informationEGFR Antibody. Necitumumab, LY , IMC-11F8. Drug Discovery Platform: Cancer Cell Signaling
EGFR Antibody Necitumumab, LY3012211, IMC-11F8 Derived from Yarden Y and Shilo BZ 1 ; Schneider MR and Wolf E. 2 Drug Discovery Platform: Cancer Cell Signaling A Single-Arm, Multicenter, Open-Label, Phase
More informationTHE HALLMARKS OF CANCER
THE HALLMARKS OF CANCER ONCOGENES - Most of the oncogenes were first identified in retroviruses: EGFR (ErbB), Src, Ras, Myc, PI3K and others (slightly more than 30) - Mutated cellular genes incorporated
More informationSupplementary Materials for
www.sciencesignaling.org/cgi/content/full/8/364/ra18/dc1 Supplementary Materials for The tyrosine phosphatase (Pez) inhibits metastasis by altering protein trafficking Leila Belle, Naveid Ali, Ana Lonic,
More informationChemo-radiation and targeted agents: biological basis
Chemoradiation and targeted agents: biological basis Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for highrisk cervical cancer. M. Morris et al, NEJM, 3:1137113,
More informationReceptor mediated Signal Transduction
Receptor mediated Signal Transduction G-protein-linked receptors adenylyl cyclase camp PKA Organization of receptor protein-tyrosine kinases From G.M. Cooper, The Cell. A molecular approach, 2004, third
More informationPredictive Assays in Radiation Therapy
Outline Predictive Assays in Radiation Therapy Radiation Biology Introduction Early predictive assays Recent trends in predictive assays Examples for specific tumors Summary Lecture 4-23-2014 Introduction
More informationGenetic Predictors of Radiosensitivity.
Genetic Predictors of Radiosensitivity. Richard G. Stock, MD Professor, Director of Genito-Urinary Oncology Department of Radiation Oncology Ichan School of Medicine at Mount Sinai New York, NY DISCLOSURE
More informationBIOCHEMISTRY REVIEW. Overview of Biomolecules. Chapter 4 Protein Sequence
BIOCHEMISTRY REVIEW Overview of Biomolecules Chapter 4 Protein Sequence 2 3 4 Are You Getting It?? A molecule of hemoglobin is compared with a molecule of lysozyme. Which characteristics do they share?
More informationIntegrating the Hallmarks of Cancer to Radiation Biology Molecular and Clinical Radiobiology Workshop McGill University Health Centre, June 17-19, 2015 ChemoRadiation Dr. Thierry Muanza Assistant Professor
More informationCombined drug and ionizing radiation: biological basis. Prof. Vincent GREGOIRE Université Catholique de Louvain, Cliniques Universitaires St-Luc
Combined drug and ionizing radiation: biological basis Prof. Vincent GREGOIRE Université Catholique de Louvain, Cliniques Universitaires St-Luc Pelvic radiation with concurrent chemotherapy compared with
More informationOncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber
Oncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber jweber@dom.wustl.edu Oncogenes & Cancer DNA Tumor Viruses Simian Virus 40 p300 prb p53 Large T Antigen Human Adenovirus p300 E1A
More informationLAB#23: Biochemical Evidence of Evolution Name: Period Date :
LAB#23: Biochemical Evidence of Name: Period Date : Laboratory Experience #23 Bridge Worth 80 Lab Minutes If two organisms have similar portions of DNA (genes), these organisms will probably make similar
More information1.The metastatic cascade. 2.Pathologic features of metastasis. 3.Therapeutic ramifications
Metastasis 1.The metastatic cascade 2.Pathologic features of metastasis 3.Therapeutic ramifications Sir James Paget (1814-1899) British Surgeon/ Pathologist Paget s disease of bone Paget s disease of the
More informationPhospho-AKT Sampler Kit
Phospho-AKT Sampler Kit E 0 5 1 0 0 3 Kits Includes Cat. Quantity Application Reactivity Source Akt (Ab-473) Antibody E021054-1 50μg/50μl IHC, WB Human, Mouse, Rat Rabbit Akt (Phospho-Ser473) Antibody
More informationMASTER EN ONCOLOGÍA MOLECULAR 2011 TGF-BETA
MASTER EN ONCOLOGÍA MOLECULAR 2011 TGF-BETA Joan Seoane ICREA Research Professor Vall d Hebron Institute of Oncology Vall d Hebron University Hospital Barcelona jseoane@vhio.net Glioma Stupp et al. New
More informationCS612 - Algorithms in Bioinformatics
Spring 2016 Protein Structure February 7, 2016 Introduction to Protein Structure A protein is a linear chain of organic molecular building blocks called amino acids. Introduction to Protein Structure Amine
More informationG-Protein Signaling. Introduction to intracellular signaling. Dr. SARRAY Sameh, Ph.D
G-Protein Signaling Introduction to intracellular signaling Dr. SARRAY Sameh, Ph.D Cell signaling Cells communicate via extracellular signaling molecules (Hormones, growth factors and neurotransmitters
More informationControl of Cell Proliferation by Peptide Growth Factors. Autocrine Growth Factor Production Causes Malignant Transformation?
Control of Cell Proliferation by Peptide Growth Factors Autocrine Growth Factor Production Causes Malignant Transformation? Transforming Activities From Condition Media from a Tumor Cell Line Condition
More informationCrosstalk between Adiponectin and IGF-IR in breast cancer. Prof. Young Jin Suh Department of Surgery The Catholic University of Korea
Crosstalk between Adiponectin and IGF-IR in breast cancer Prof. Young Jin Suh Department of Surgery The Catholic University of Korea Obesity Chronic, multifactorial disorder Hypertrophy and hyperplasia
More informationProperties of amino acids in proteins
Properties of amino acids in proteins one of the primary roles of DNA (but far from the only one!!!) is to code for proteins A typical bacterium builds thousands types of proteins, all from ~20 amino acids
More informationAmino Acids. Amino Acids. Fundamentals. While their name implies that amino acids are compounds that contain an NH. 3 and CO NH 3
Fundamentals While their name implies that amino acids are compounds that contain an 2 group and a 2 group, these groups are actually present as 3 and 2 respectively. They are classified as α, β, γ, etc..
More informationIntroduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.
Cancer Biology Chapter 18 Eric J. Hall., Amato Giaccia, Radiobiology for the Radiologist Introduction Tissue homeostasis depends on the regulated cell division and self-elimination (programmed cell death)
More informationCANCER THERAPEUTICS: A NOVEL APPROACH
CANCER THERAPEUTICS: A NOVEL APPROACH Mary Dwyer, Ph.D. HBRI and ChemRegen, Inc. SCDMDG Meeting October 23, 212 Outline Introduction Hit, HBRI1: identification & characterization Leads, HBRI2 & HBRI3:
More informationProteins are sometimes only produced in one cell type or cell compartment (brain has 15,000 expressed proteins, gut has 2,000).
Lecture 2: Principles of Protein Structure: Amino Acids Why study proteins? Proteins underpin every aspect of biological activity and therefore are targets for drug design and medicinal therapy, and in
More informationnumber Done by Corrected by Doctor Maha Shomaf
number 19 Done by Waseem Abo-Obeida Corrected by Abdullah Zreiqat Doctor Maha Shomaf Carcinogenesis: the molecular basis of cancer. Non-lethal genetic damage lies at the heart of carcinogenesis and leads
More informationCancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation
Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated
More informationCancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation
Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated
More informationIssue Date Right.
NAOSITE: Nagasaki University's Ac Title Role of Nuclear EGFR During Cellula Author(s) Dittmann H. Klaus; Mayer, Claus; Ro Citation Acta medica Nagasakiensia, 53(supl. Issue Date 2009-03 URL http://hdl.handle.net/10069/21800
More informationBasics of Radiation Biology
Basics of Radiation Biology Sally A. Amundson Columbia University Center for Radiological Research http://www.cmcr.columbia.edu/ Overview Radiation damage to cells DNA Effects of radiation damage on cells
More informationBasics of Radiation Biology
Basics of Radiation Biology Sally A. Amundson Columbia University Center for Radiological Research http://www.cmcr.columbia.edu/ Overview Radiation damage to cells DNA Effects of radiation damage on cells
More informationGrowth and Differentiation Phosphorylation Sampler Kit
Growth and Differentiation Phosphorylation Sampler Kit E 0 5 1 0 1 4 Kits Includes Cat. Quantity Application Reactivity Source Akt (Phospho-Ser473) E011054-1 50μg/50μl IHC, WB Human, Mouse, Rat Rabbit
More informationTargeted Therapies: Radiosensitizing Effects of Kinase Inhibitors
Targeted Therapies: Radiosensitizing Effects of Kinase Inhibitors Molecular and Clinical Radiobiology Workshop McGill University Health Centre, June 17-19, 2015 Bertrand J. Jean-Claude, PhD Associate Professor,
More informationLung cancer is one of the most lethal forms of cancer,
STATE OF THE ART: CONCISE REVIEW The PI3-K/AKT-Pathway and Radiation Resistance Mechanisms in Non-small Cell Lung Cancer Olga C.J. Schuurbiers, MD,* Johannes H.A.M. Kaanders, MD, PhD, Henricus F.M. van
More informationBL-8040: BEST-IN-CLASS CXCR4 ANTAGONIST FOR TREATMENT OF ONCOLOGICAL MALIGNANCIES. Overview and Mechanism of Action Dr.
BL-8040: BEST-IN-CLASS CXCR4 ANTAGONIST FOR TREATMENT OF ONCOLOGICAL MALIGNANCIES Overview and Mechanism of Action Dr. Leah Klapper, CSO 88 BL-8040: Novel CXCR4 Antagonist For Hematological Cancers Indications:
More information1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples. Major Principles:
Carcinogenesis 1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples Carcinogenesis Major Principles: 1. Nonlethal genetic damage is central to
More informationFigure S1. Effect of bafilomycin on EGF-induced Akt and Erk signaling. Effect of chloroquine on EGF-stimulated mtorc1, Akt and Erk
EGF induced VATPase assembly and mtorc1 activation Supplemental Information Supplemental Figure Legends Figure S1. Effect of bafilomycin on EGFinduced Akt and Erk signaling. A. Hepatocytes were treated
More informationROLE OF TGF-BETA SIGNALING IN PIK3CA-
ROLE OF TGF-BETA SIGNALING IN - DRIVEN HEAD AND NECK CANCER INVASION AND METASTASIS 1,2 Sophia Bornstein, 3 Jingping Shen, 3 Jacob Minor, 3 Frank Hall, 3 Fang Zhang, 4 Sherif Said, 4 Xiao-Jing Wang, 1
More information1. Describe the relationship of dietary protein and the health of major body systems.
Food Explorations Lab I: The Building Blocks STUDENT LAB INVESTIGATIONS Name: Lab Overview In this investigation, you will be constructing animal and plant proteins using beads to represent the amino acids.
More informationNon Small Cell Lung Cancer Histopathology ד"ר יהודית זנדבנק
Non Small Cell Lung Cancer Histopathology ד"ר יהודית זנדבנק 26.06.09 Lecture outlines WHO histological classification Macro/Micro assessment Early diagnosis Minimal pathology Main subtypes SCC, AdCa, LCLC
More informationOutline. Inter-patient variability. Incorporation within TCP models. Molecular profiling why?
Mayneord-Phillips Summer School 29 Oxford Inter-patient variability: predictive assays, gene expression profiles Catharine West The University of Manchester Christie Hospital Catharine.West@manchester.ac.uk
More informationThe biological bases of treatment related cardiac and lung toxicity
The biological bases of treatment related cardiac and lung toxicity Monica Mangoni Cardiopulmonary toxicity of anticancer treatments Chemotherapy TKIs MoAB CARDIAC TOXICITY Radiation effect -------------------------------Early
More informationGenetics of Cancer Lecture 32 Cancer II. Prof. Bevin Engelward, MIT Biological Engineering Department
Genetics of Cancer Lecture 32 Cancer II rof. Bevin Engelward, MIT Biological Engineering Department Why Cancer Matters New Cancer Cases in 1997 Cancer Deaths in 1997 Genetics of Cancer: Today: What types
More informationI TESSUTI: Dott.ssa Liliana Belgioia Università degli Studi di Genova
I TESSUTI: 1. Repair, Radiosensitivity, Recruitment, Repopulation, Reoxygenation 2. Acute and chronic hypoxia 3. Tissue microenvironment and tissue organization Dott.ssa Liliana Belgioia Università degli
More informationAntitumor Activity of CUDC-305, a Novel Oral HSP90 Inhibitor, in Solid and Hematological Tumor Xenograft Models
Antitumor Activity of CUDC-5, a Novel Oral HSP Inhibitor, in Solid and Hematological Tumor Xenograft Models Rudi Bao, MD/PhD April 1, 2 AACR 1th Annual Meeting 2 Experimental and Molecular Therapeutics
More informationKRAS: ONE ACTOR, MANY POTENTIAL ROLES IN DIAGNOSIS
UNIVERSITÀ DEGLI STUDI DI PALERMO Scuola di Specializzazione in Biochimica Clinica Direttore Prof. Marcello Ciaccio KRAS: ONE ACTOR, MANY POTENTIAL ROLES IN DIAGNOSIS Loredana Bruno KRAS gene Proto-oncogene
More informationGFP Assays
GFP Assays 2009-07-03 GFP Assays Akt1 SMAD2 STAT3 NFAT-C1 MAPKAP-k2 Rac-1 PLCδ PH domain FYVE G2M CCPM Cell survival, proliferation, apoptosis, insulin response pathways TGF-beta signalling, growth, differentiation,
More informationIs there a role for EGFR Tyrosine Kinase Inhibitors in recurrent glioblastoma?
Is there a role for EGFR Tyrosine Kinase Inhibitors in recurrent glioblastoma? Juan M Sepúlveda Sánchez Neurooncology Unit Hospital Universitario 12 de Octubre. Madrid Topics 1.-EGFR pathway as a potential
More informationGenetics and Cancer Ch 20
Genetics and Cancer Ch 20 Cancer is genetic Hereditary cancers Predisposition genes Ex. some forms of colon cancer Sporadic cancers ~90% of cancers Descendants of cancerous cells all cancerous (clonal)
More informationTransgenic Mice and Genetargeting
Transgenic Mice and Genetargeting mice In Biomedical Science Techniques of transgenic and gene-targeting mice are indispensable for analyses of in vivo functions of particular genes and roles of their
More informationBiol403 MAP kinase signalling
Biol403 MAP kinase signalling The mitogen activated protein kinase (MAPK) pathway is a signalling cascade activated by a diverse range of effectors. The cascade regulates many cellular activities including
More informationDual targeting of PI3K and MEK enhances the radiation response of K-RAS mutated non-small cell lung cancer
/, Vol. 7, No. 28 Dual targeting of PI3K and MEK enhances the radiation response of K-RAS mutated non-small cell lung cancer Mahmoud Toulany 1, Mari Iida 2, Simone Keinath 1, Firdevs F. Iyi 1, Katharina
More informationTumor cell reassortment within the cell cycle (including checkpoints and cell-cycle arrest)
Tumor cell reassortment within the cell cycle (including checkpoints and cell-cycle arrest) Carsten Herskind Dept. of Radiation Oncology. Universitätsmedizin Mannheim Medical Faculty Mannheim, Heidelberg
More informationRAS Genes. The ras superfamily of genes encodes small GTP binding proteins that are responsible for the regulation of many cellular processes.
۱ RAS Genes The ras superfamily of genes encodes small GTP binding proteins that are responsible for the regulation of many cellular processes. Oncogenic ras genes in human cells include H ras, N ras,
More informationPLX7486 Background Information October Candidate for CRUK Combinations Alliance
PLX7486 Background Information October 2015 Candidate for CRUK Combinations Alliance 1 Oct 2015 Plexxikon s Development Pipeline Compound Target Cancer Indication Stage of Development Pre- IND Ph1 Ph2
More informationKevin R. Fox, MD Rena Rowan Breast Center Abramson Cancer Center University of Pennsylvania Perelman School of MedicineR
Kevin R. Fox, MD Rena Rowan Breast Center Abramson Cancer Center University of Pennsylvania Perelman School of MedicineR Treatment of early stage, HER2 positive breast cancer Treatment of early stage,
More informationEts-1 identifying polynucleotide sequence for targeted delivery of anti-cancer drugs
Ets-1 identifying polynucleotide sequence for targeted delivery of anti-cancer drugs Indian Patent Application No. 1623/DEL/2014 Inventors: Prof. Kulbhushan Tikoo and Jasmine Kaur Department of Pharmacology
More informationCancer. Questions about cancer. What is cancer? What causes unregulated cell growth? What regulates cell growth? What causes DNA damage?
Questions about cancer What is cancer? Cancer Gil McVean, Department of Statistics, Oxford What causes unregulated cell growth? What regulates cell growth? What causes DNA damage? What are the steps in
More informationConcise Reference. HER2 Testing in Breast Cancer. Mary Falzon, Angelica Fasolo, Michael Gandy, Luca Gianni & Stefania Zambelli
Concise Reference Testing in Breast Cancer Mary Falzon, Angelica Fasolo, Michael Gandy, Luca Gianni & Stefania Zambelli Extracted from Handbook of -Targeted Agents in Breast Cancer ublished by Springer
More informationClustered mutations of oncogenes and tumor suppressors.
Supplementary Figure 1 Clustered mutations of oncogenes and tumor suppressors. For each oncogene (red dots) and tumor suppressor (blue dots), the number of mutations found in an intramolecular cluster
More informationTissue Factor/PAR2 signaling enhances the malignancy and radiation resistance of lung cancer brain metastases
Tissue Factor/PAR2 signaling enhances the malignancy and radiation resistance of lung cancer brain metastases Dusten Unruh, PhD 8 th Annual Brain Metastases Research and Emerging Therapy Conference Tissue
More informationFile Name: Supplementary Information Description: Supplementary Figures and Supplementary Tables. File Name: Peer Review File Description:
File Name: Supplementary Information Description: Supplementary Figures and Supplementary Tables File Name: Peer Review File Description: Primer Name Sequence (5'-3') AT ( C) RT-PCR USP21 F 5'-TTCCCATGGCTCCTTCCACATGAT-3'
More informationCancer genetics
Cancer genetics General information about tumorogenesis. Cancer induced by viruses. The role of somatic mutations in cancer production. Oncogenes and Tumor Suppressor Genes (TSG). Hereditary cancer. 1
More informationSynthesis and Biological Evaluation of Protein Kinase D Inhibitors
Synthesis and Biological Evaluation of Protein Kinase D Inhibitors Celeste Alverez Topic Seminar October 26, 2013 Celeste Alverez @ Wipf Group 10/26/2013 1 Protein Kinase D (PKD) A novel family of serine/threonine
More informationRadiation Oncology. Initial Certification Qualifying (Computer-based) Examination: Study Guide for Radiation and Cancer Biology
Radiation Oncology Initial Certification Qualifying (Computer-based) Examination: Study Guide for Radiation and Cancer Biology This exam tests your knowledge of the principles of cancer and radiation biology
More informationSupplementary Fig. 1. GPRC5A post-transcriptionally down-regulates EGFR expression. (a) Plot of the changes in steady state mrna levels versus
Supplementary Fig. 1. GPRC5A post-transcriptionally down-regulates EGFR expression. (a) Plot of the changes in steady state mrna levels versus changes in corresponding proteins between wild type and Gprc5a-/-
More informationSupplementary Figure-1. SDS PAGE analysis of purified designed carbonic anhydrase enzymes. M1-M4 shown in lanes 1-4, respectively, with molecular
Supplementary Figure-1. SDS PAGE analysis of purified designed carbonic anhydrase enzymes. M1-M4 shown in lanes 1-4, respectively, with molecular weight markers (M). Supplementary Figure-2. Overlay of
More informationHow genetic & biochemical alterations in brain tumors contribute to epileptogenesis
How genetic & biochemical alterations in brain tumors contribute to epileptogenesis December 2 nd, 2012 Joon H. Uhm, MD FRCPC Departments of Neurology & Oncology Mayo Clinic, Rochester, MN American Epilepsy
More informationSupplementary Figure 1: High-throughput profiling of survival after exposure to - radiation. (a) Cells were plated in at least 7 wells in a 384-well
Supplementary Figure 1: High-throughput profiling of survival after exposure to - radiation. (a) Cells were plated in at least 7 wells in a 384-well plate at cell densities ranging from 25-225 cells in
More informationDetermination Differentiation. determinated precursor specialized cell
Biology of Cancer -Developmental Biology: Determination and Differentiation -Cell Cycle Regulation -Tumor genes: Proto-Oncogenes, Tumor supressor genes -Tumor-Progression -Example for Tumor-Progression:
More informationCopyright 2008 Pearson Education, Inc., publishing as Pearson Benjamin Cummings
Concept 5.4: Proteins have many structures, resulting in a wide range of functions Proteins account for more than 50% of the dry mass of most cells Protein functions include structural support, storage,
More informationThe Impact of Bystander Effects and Adaptive Responses in the Health Risks of Low Dose Ionizing Radiation
The Impact of Bystander Effects and Adaptive Responses in the Health Risks of Low Dose Ionizing Radiation Edouard Azzam New Jersey Medical School Newark, USA Two phenomena have been recently implicated
More informationNimotuzumab Paul Keane MD, FRCPC, FACP, FRC Path
Nimotuzumab Paul Keane MD, FRCPC, FACP, FRC Path Research & Development Day Wednesday April 5, 2006 Harvard Club New York City EGFR The EGFR is a member of the ErbB family of tyrosine kinase (TK) receptors
More informationINNOVAZIONI TERAPEUTICHE IN ONCOLOGIA MEDICA CAGLIARI GIUGNO 2005 Policlinico Universitario - Cagliari LAPATINIB
INNOVAZIONI TERAPEUTICHE IN ONCOLOGIA MEDICA CAGLIARI 23-24 GIUGNO 2005 Policlinico Universitario - Cagliari LAPATINIB Elena Massa CATTEDRA DI ONCOLOGIA MEDICA UNIVERSITA DEGLI STUDI DI CAGLIARI ErbB Inhibition
More informationTargeting the ERBB family in cancer: couples therapy
OPINION Targeting the ERBB family in cancer: couples therapy Niall Tebbutt, Mikkel W. Pedersen and Terrance G. Johns Abstract The ERBB family of receptor tyrosine kinases has a central role in the tumorigenesis
More informationRadioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition
/, Vol. 6, No. 42 Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition Roberto Gomez-Casal 1,2, Michael W. Epperly 1,3,
More informationRegarding techniques of proteomics, there is:
Molecular الحلقة biology 14 واألخيرة To put you back in the context; the discussion was about Trancriptomics (the study of transcription). The following topic will be PROTEOMICS, which is the study of
More informationInsulin Resistance. Biol 405 Molecular Medicine
Insulin Resistance Biol 405 Molecular Medicine Insulin resistance: a subnormal biological response to insulin. Defects of either insulin secretion or insulin action can cause diabetes mellitus. Insulin-dependent
More informationTargeting PPIs in Oncology using a Fragment-Based Drug Discovery Approach Justin F. Bower CRUK Beatson Institute
Targeting PPIs in Oncology using a Fragment-Based Drug Discovery Approach Justin F. Bower CRUK Beatson Institute Cancer Research UK Beatson Institute Establish an outstanding basic research programme into
More informationMolecular pathogenesis of lung cancer
Molecular pathogenesis of lung cancer Pr. Elisabeth Brambilla INSERM U823 Department of Pathology CHU Grenoble France Lung epithelial cells Carcinogen exposure genetic predisposition Auto- and paracrine
More informationPhoto Aging. Medical Ecology Of Stratospheric Ozone Depletion: Impacts on the Human Condition. Breakup Of The Ward Ice Shelf Antarctica 2004
Breakup Of The Ward Ice Shelf Antarctica 2004 http://sedac.ciesin.org/ozone/docs/uvd-home.html Medical Ecology Of Stratospheric Ozone Depletion: Photo Aging Impacts on the Human Condition 1 UVB Solar Radiation
More informationBreakup Of The Ward Ice Shelf Antarctica 2004
Breakup Of The Ward Ice Shelf Antarctica 2004 http://sedac.ciesin.org/ozone/docs/uvd-home.html Medical Ecology Of Stratospheric Ozone Depletion: Impacts on the Human Condition Photo Aging UVB Solar Radiation
More informationHuman Lung Cancer Pathology and Cellular Biology Mouse Lung Tumor Workshop
Human Lung Cancer Pathology and Cellular Biology Mouse Lung Tumor Workshop Jan 7 th and 8 th, 2014 Brigitte Gomperts, MD University of California, Los Angeles Lung Structure and Function Airway Epithelial
More information